- (11): 104. doi:10.1038/s41408-018-0142-z. PMC 6221891. PMID 30405096.
Tefferi A (September 2014). "Primary myelofibrosis: 2014
update on diagnosis, risk-stratification...
- Encyclopædia Britannica. 2010. Encyclopædia
Britannica Online. 21 Sep. 2010
Tefferi A,
Lasho TL,
Guglielmelli P,
Finke CM,
Rotunno G,
Elala Y, et al. (2016)...
- 976–983. doi:10.1111/j.1742-1241.2012.02986.x. PMC 3469735. PMID 22889110.
Tefferi, A (March 2011). "Annual
Clinical Updates in
Hematological Malignancies:...
- 05535.x. PMID 16029446. S2CID 11681060.
Gangat N,
Szuber N,
Pardanani A,
Tefferi A (August 2021). "JAK2
unmutated erythrocytosis:
current diagnostic approach...
- Michael; Vannucchi,
Alessandro M.; Guglielmelli, Paola; Orazi, Attilio;
Tefferi,
Ayalew (2018-02-09). "The 2016 WHO
classification and
diagnostic criteria...
- 340.1412R. doi:10.1126/science.1241318. PMID 23788787. S2CID 206550237.
Tefferi A (2006). "classification,
diagnosis and
management of myeloproliferative...
-
neoplasms and psoriasis". IDrugs. 13 (6): 394–403. PMID 20506062.
Pardanani A,
Tefferi A (March 2011). "Targeting
myeloproliferative neoplasms with JAK inhibitors"...
- the
original on 3 July 2009. Lim KH,
Pardanani A,
Butterfield JH, Li CY,
Tefferi A (December 2009). "Cytoreductive
therapy in 108
adults with
systemic mastocytosis:...
- Maru
Abinet Teferi (Amharic: ማሩ ኣቢነት ተፈሪ; Hebrew: מארו אבינת טפרי; born 17
August 1992), also
known as
Teferi Marhu, is an
Israeli marathon and half marathon...
- C,
Cortes JE,
Talpaz M,
Stone RM,
Silverman MH,
Gilliland DG,
Shorr J,
Tefferi A (March 2011). "Safety and
efficacy of TG101348, a
selective JAK2 inhibitor...
